Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivocasan in Chronic Hepatitis C
NCT00725803Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of nivocasan in hepatitis C (HCV), sponsored by Gilead Sciences. Started Apr 2008; status: completed.
02
Drugs
nivocasan
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00725803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725803.